Cystitis Clinical Trial
Official title:
Prospective Study on the Efficacy and Safety of Uronext® in Parallel Groups in Women With Cystitis in the Acute Stage
The study is designed as a prospective parallel open label, two-arm, single center study exploring efficacy and safety of the use of the dietary supplement Uronext in women with cystitis in the acute stage. 120 otherwise healthy women with acute cystitis infection confirmed with the urine bacteriological examinations, aged 18-18 years, will be recruited. The distribution of patients will be done in 1:1 ratio. Control group will receive standard therapy, Monural (fosfomycin trometamol) 3 g, at the first day of the trial. The second group will also receive Monural (fosfomycin trometamol) 3 g, at the first day of the trial as well as Uronext food supplement, 1 time per day for the first 7 days. After the 7 day break, participants in the second group will follow supplementation scheme for the next 3 month. Primary objective of the study is evaluation of the effectiveness of the dietary supplement Uronext in women with cystitis in the acute stage in the prevention of subsequent exacerbations of recurrent cystitis during 3 months of observation, measured as the number of relapses throughout the study period. Participnats will also fill in urination diary and questionnaires related to pain perception, quality of life and cystitis symptoms. Urine samples will be further examined at the follow up visits. Safety will be evaluated based on reported adverse events, assessment of vital signs and laboratory evaluation.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Withdrawn |
NCT00361998 -
Nitrofurantoin Macrocrystals 3 Days Versus 7 Days in the Treatment of Women With Uncomplicated Cystitis
|
Phase 4 | |
| Completed |
NCT03275623 -
Management of Sub-Clinical Bacteriuria in Pregnancy
|
Phase 4 | |
| Not yet recruiting |
NCT05055544 -
Bearberry in the Treatment of Cystitis
|
N/A | |
| Active, not recruiting |
NCT01966653 -
Study Comparing Nitrofurantoin to Fosfomycin for Acute Urinary Tract Infection in Women
|
Phase 4 | |
| Withdrawn |
NCT01527019 -
Comparison in the Treatment of Acute Cystitis Using Cephalosporin and Norfloxacin (CECI)
|
Phase 3 | |
| Completed |
NCT03877289 -
Efficacy of Oxybutynin in Paediatric Cystitis
|
Phase 4 | |
| Completed |
NCT05584657 -
Oral Sulopenem Versus Amoxicillin/Clavulanate for Uncomplicated Urinary Tract Infection in Adult Women
|
Phase 3 | |
| Terminated |
NCT00164099 -
The Role of Synbiotics in Reducing Post-Operative Infections in Patients Undergoing Cardiac Surgery: A Pilot Study
|
Phase 4 | |
| Completed |
NCT00528476 -
Risk Factors for Recurrent Urinary Tract Infection in Children
|
N/A | |
| Completed |
NCT04987164 -
Incidence of Cystitis in Women Consuming a Mixture of Cranberry, Cinnamon, Probiotics
|
||
| Completed |
NCT01861353 -
Cranberry-lingonberry Juice Started During Acute Infection in Prevention of Urinary Tract Infections in Children
|
N/A | |
| Completed |
NCT00957333 -
Effects of Ketamine on Human Bladders and Its Possible Mechanisms
|
N/A | |
| Recruiting |
NCT05360914 -
Hospital at Home for Elderly Acute Ill Patients
|
N/A | |
| Completed |
NCT04272281 -
Use of a Share Decision Making Tool in the Care of Acute Cystitis Without Risk of Complication in Primary Care
|
N/A | |
| Completed |
NCT03425396 -
Oral Omadacycline vs. Oral Nitrofurantoin for the Treatment of Cystitis
|
Phase 2 | |
| Completed |
NCT05260554 -
Effect of Cranberry Extract on the Urinary System
|
||
| Unknown status |
NCT00622076 -
Postoperative Catheterization After Anterior Colporrhaphy
|
N/A | |
| Completed |
NCT00801021 -
Treatment and/or Prevention of Urinary Tract Infections
|
Phase 1 | |
| Terminated |
NCT01060254 -
A Study to Evaluate the Pain Relieving Effects, Safety, and Tolerability of JNJ-42160443 for the Relief of Bladder Pain
|
Phase 2 | |
| Not yet recruiting |
NCT06391164 -
Study to Evaluate the Efficacy and Safety of XC243 in Patients With Exacerbation of Chronic Cystitis
|
Phase 2 |